Victrex Valuation

Is 1OY undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 1OY when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 1OY (€12.2) is trading below our estimate of fair value (€23.88)

Significantly Below Fair Value: 1OY is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 1OY?

Key metric: As 1OY is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 1OY. This is calculated by dividing 1OY's market cap by their current earnings.
What is 1OY's PE Ratio?
PE Ratio54.3x
EarningsUK£17.20m
Market CapUK£933.94m

Price to Earnings Ratio vs Peers

How does 1OY's PE Ratio compare to its peers?

The above table shows the PE ratio for 1OY vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average20.8x
ACT AlzChem Group
11.8x12.8%€590.2m
WCH Wacker Chemie
27.7x36.4%€3.4b
UZU Uzin Utz
10.2x2.1%€245.2m
EVK Evonik Industries
33.5x32.9%€7.7b
1OY Victrex
54.3x29.3%€933.9m

Price-To-Earnings vs Peers: 1OY is expensive based on its Price-To-Earnings Ratio (54.3x) compared to the peer average (20.8x).


Price to Earnings Ratio vs Industry

How does 1OY's PE Ratio compare vs other companies in the European Chemicals Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
1OY 54.3xIndustry Avg. 16.9xNo. of Companies12PE01224364860+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 1OY is expensive based on its Price-To-Earnings Ratio (54.3x) compared to the European Chemicals industry average (16.9x).


Price to Earnings Ratio vs Fair Ratio

What is 1OY's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

1OY PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio54.3x
Fair PE Ratio21.1x

Price-To-Earnings vs Fair Ratio: 1OY is expensive based on its Price-To-Earnings Ratio (54.3x) compared to the estimated Fair Price-To-Earnings Ratio (21.1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 1OY forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€12.20
€15.24
+24.9%
17.0%€20.26€12.06n/a12
Dec ’25€10.20
€15.40
+50.9%
17.8%€20.11€10.18n/a12
Nov ’25€10.20
€15.40
+50.9%
17.8%€20.11€10.18n/a12
Oct ’25€11.50
€15.79
+37.3%
14.8%€20.16€12.00n/a12
Sep ’25€12.10
€15.64
+29.3%
14.8%€19.97€11.89n/a12
Aug ’25€12.80
€16.36
+27.8%
12.7%€19.96€13.66n/a12
Jul ’25€13.40
€16.90
+26.1%
12.2%€20.80€13.67n/a12
Jun ’25€14.50
€17.26
+19.0%
13.8%€21.06€13.46n/a12
May ’25€14.70
€17.57
+19.5%
13.3%€20.90€13.82n/a12
Apr ’25€14.60
€17.85
+22.3%
14.8%€21.43€13.94n/a11
Mar ’25€14.40
€17.78
+23.5%
14.2%€21.39€13.91n/a12
Feb ’25€15.80
€18.28
+15.7%
13.2%€21.43€13.93n/a12
Jan ’25€17.20
€19.14
+11.3%
14.6%€24.26€14.51n/a13
Dec ’24€16.40
€18.91
+15.3%
14.2%€23.88€14.28€10.2013
Nov ’24€15.30
€18.94
+23.8%
14.5%€24.03€14.37€10.2013
Oct ’24€16.20
€19.68
+21.5%
13.9%€24.21€15.33€11.5014
Sep ’24€17.50
€20.09
+14.8%
13.0%€24.47€15.50€12.1014
Aug ’24€17.50
€20.10
+14.9%
12.8%€24.39€15.45€12.8014
Jul ’24€15.80
€20.54
+30.0%
12.8%€24.52€16.93€13.4014
Jun ’24€17.90
€21.90
+22.4%
14.7%€26.60€16.77€14.5014
May ’24€18.40
€22.52
+22.4%
12.9%€26.23€17.34€14.7014
Apr ’24€17.70
€22.81
+28.9%
12.6%€26.27€17.29€14.6015
Mar ’24€19.50
€22.89
+17.4%
11.9%€26.24€18.18€14.4015
Feb ’24€20.60
€22.95
+11.4%
10.5%€26.08€18.14€15.8015
Jan ’24€17.80
€23.02
+29.3%
10.6%€26.19€18.22€17.2015
Dec ’23€20.20
€24.08
+19.2%
13.5%€31.56€18.46€16.4015

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 19:27
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Victrex plc is covered by 33 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gunther ZechmannBarclays
James StewartBarclays
Sebastian BrayBerenberg